 The active ingredient is iliprost, a vasodilator that prevents blood from clotting, showcasing efficacy in treating frostbite patients, according to the FDA. Its efficacy in treating severe frostbite was established in the controlled trial that occurred between 1996 and 2008, the agency said. So there's a controlled trial between 1996 and 2008. It is 2024.